astrazeneca glp-1 AstraZeneca’s experimental obesity pill helped patients lose up to 11.8% of their body weight in a mid-stage trial, as competition intensifies in the rapidly growing market for oral weight-loss drugs. Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists
Description
IM GLP Reset is a next-generation formula designed to promote digestive wellness, metabolic balance, and microbiome support all in one daily capsule

Ozempic is an FDA-approvedGLP-1
Weight loss does not equal body sculpting
Perfect trial size to experience the formula before committing to a larger pack
